Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin (PPS and IGIV)
Status
Conditions
Details and patient eligibility
About
Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital
Full description
Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the department of MPR on the criteria of judgment, then the patient is admitted in a service of neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service for post-treatment evaluation.
Collection of data retrospectively.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Diagnosis of PPS
- Pre- and post-therapeutic evaluation carried out
- Data transcribed in the computerized patient file
Exclusion criteria
- No walking patient
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal